This implies that inducing the HB-EGF release by hCAP18/LL-37 is an important way to activate EGFR/HER2 in HCC cells, although how hCAP18/LL-37 regulates HB-EGF release is still unknown. Here, EGF is linked to hepatocellular carcinoma.